# Serum Anti-mullerian Hormone and Polycystic Ovarian Syndrome

> **NCT03237312** · PHASE2 · COMPLETED · sponsor: **Assiut University** · enrollment: 50 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **PROCEDURE:** Laparoscopic ovarian drilling
- **BIOLOGICAL:** Antimullerian hormone

## Key facts

- **NCT ID:** NCT03237312
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2016-09-30
- **Final completion:** 2016-11-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03237312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03237312, "Serum Anti-mullerian Hormone and Polycystic Ovarian Syndrome". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03237312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*